Until now, biologists have only had crude methods for estimating the average rates and effects of mutations. But in a new study, biophysicists have documented individual mutations as they happen in bacterial cells.
Young, resting neural stem cells have large protein clumps often associated with neurodegeneration. As stem cells age, the aggregates inhibit their ability to make new neurons, researchers say.
Patients who beat cancer years or even decades ago still become fatigued more quickly than people without cancer histories, a new study shows.
The Securities and Exchange Commission (SEC) has has charged Theranos and its chief executive Elizabeth Holmes with “massive fraud.”
FDA Commissioner, Scott Gottlieb has critiqued health insurers, as he homes in on the increasingly popular target of rebates in the drug pricing debate.
UK workers within sales, marketing and PR have the highest median salary (£47,000), followed by those working in bioinformatics and data science (£44,090), according to our report.
Biological engineers from the Massachusetts Institute of Technology have discovered why a promising drug failed in clinical trials.
New finding suggests differences in how humans and bacteria control production of DNA’s building blocks.
Artificial Intelligence has been going from strength to strength in recent weeks, but its potential doesn’t mean that the diagnostic is ready for the clinic.
As of yesterday, Rob Brainin, Executive Vice President and Chief Operating Officer, has been appointed as the company’s new Chief Executive Officer.
How can researchers determine the best path forward when so many studies are coming out, each with new information?
Researchers have created the world’s first synthetic, non-biologic vaccine. The influenza vaccine, which can be delivered orally, could herald a revolution in vaccine delivery.
Men and women suffering from Major Depressive Disorder (MDD) experience opposite changes in gene expression of the same loci, according to a new study.
The fragile X syndrome is the most common form of intellectual impairment in men, affecting 1 out of 3,600 boys. Scientists have used CRISPR to restore its activity.
Scientists have linked 110 genes to an increased risk of breast cancer in the most comprehensive study ever to unpick the genetics of the disease.